Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients

British Journal of Ophthalmology

Volumn 82, Issue 9, 1998, Pages 988-990

  Van Den Horn, Gerardus J ^a   Meenken, Christina ^a   Danner, Sven A ^a   Reiss, Peter ^a   De Smet, Marc D ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; EYE INFLAMMATION; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK;

EID: 0031706007     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.9.988     Document Type: Article

References (12)

1. Notermans DW, de Wolf F, Foudraine NA, et al. The effects of an antiretroviral triple combination with ritonavir, AZT, and 3-TC. Third International Congress on Drug Therapy in HIV infection. Birmingham, UK, 1996. AIDS 1996;10 (suppl 2): abstract OP9.1: S17.
2. Gulick RM, Mellors J, Havlir D, et al. Potent and sustained antiretroviral activity of indinavir, zidovudine and lamivudine. XIth International Conference on AIDS. Vancouver, 1996 (abstract Th.B.931).
3. Elliot B, Aromin I, Gold R, et al. 2.5 Year remission of AIDS associated progressive multifocal leukencephalopathy with combined antiretroviral therapy. Lancet 1997;349:850.
4. Power C, Nath A, Aoki FY, et al. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med 1997;336:661-2.
5. Murphy M, Armstrong D, Sephowitz KA, et al. Regression of AIDS-related Kaposi's sarcoma following treatment with a HIV-1 protease inhibitor. AIDS 1997;11:261-2.
6. Carr A, Foudraine N, Reiss P, et al. Resolution of antibioticresistant cryptosporidiosis and microsporidiosis with potent combination antiretioviral therapy. 4th Conference on Retroviruses and Opportunistic Infections, Washington, 1997 (abstract 688).
7. Benhamou Y, Bochet MV, Carriere J, et al. Effects of triple antiretroviral therapy including an HIV protease inhibitor on chronic intestinal cryptosporidiosis and microsporidiosis in HIV-infected patients. 4th Conference on Retroviruses and Opportunistic Infections, Washington, 1997 (abstract 357).
8. Carr A, Cooper DA. Restoration of immunity to chronic hepatitis B infection in HIV infected patients on protease inhibitor. Lancet 1997;349:995-6.
9. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 1997;349:1443-5.
10. Rasmussen L, Morris S, Zipeto D, et al. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J Infect Dis 1995;171: 177-82.
11. Spector SA, Picher M, Lamy P, et al. PCR of plasma for cytomegalovirus DNA identifies HIV-infected persons most likely to benefit from oral ganciclovir prophylaxis. XIth International Conference on AIDS. Vancouver, 1996 (abstract Th.B. 302).
12. Dodt KK, Jacobsen PH, Hofman B, et al. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 1997;11:21-8.